Search Results - "Katavetin, P"

Antioxidative effects of erythropoietin by Katavetin, P., Tungsanga, K., Eiam-Ong, S., Nangaku, M.

“…Erythropoietin (EPO) has been shown to exert cytoprotective effects on erythroid progenitor cells as well as various non-erythroid cells. Experimental studies…”
Get full text

Tidying up the peritoneal dialysis modality classification: a proposal by Katavetin, P, Saiprasertkit, N, Kanjanabuch, T

Get full text

A novel simple hemoglobin dilution technique to measure hemodialysis vascular access flow by Tiranathanagul, K., Katavetin, P., Injan, P., Leelahavanichkul, A., Techawathanawanna, N., Praditpornsilpa, K., Srisawat, N., Tungsanga, K., Eiam-Ong, S.

“…Measurement of the vascular access flow rate (Qa) is a widely accepted method for surveillance and predicting access failure. Among current practical methods,…”
Get full text

WCN23-0536 RENAL FUNCTION DECLINE IN TYPE 2 DIABETIC PATIENTS WITH NORMAL TO MODERATELY INCREASED ALBUMINURIA: A 15-YEAR FOLLOW-UP STUDY by JINTANAPRAMOTE, K., Katavetin, P.

Get full text

WCN23-0287 THE INCIDENCE OF ACUTE KIDNEY INJURY IN PATIENTS UNDERGOING COMPUTERIZED TOMOGRAPHY SCANS by JIAMJAIPAIBOON, W., Katavetin, P.

Get full text

410P The incidence and risk factors of kidney injury in patients receiving immune checkpoint inhibitors: A retrospective observational cohort study by Suksomboon, T., Sitthideatphaiboon, P., Phannajit, J., Katavetin, P.

Get full text

Comparison of middle-molecule clearance between convective control double high-flux hemodiafiltration and on-line hemodiafiltration by Tiranathanagul, K, Yossundharakul, C, Techawathanawanna, N, Katavetin, P, Hanvivatvong, O, Praditpornsilp, K, Tungsanga, K, Eiam-Ong, S

“…Hemodiafiltration (HDF) is now a well-recognized treatment modality for end-stage renal disease (ESRD) patients. It provides superior characteristics over…”
Get full text

WCN23-0568 PREVALENCE AND PROGNOSTIC OF OBESITY-RELATED GLOMERULOPATHY by THONGSRICOME, T., Greeviroj, P., Puapatanakul, P., Boonchayaanant, P., Susantitaphong, P., Katavetin, P.

Get full text

WCN23-0397 EFFECT OF CANAGLIFLOZIN IN NON-DIABETIC OBESE PATIENTS WITH ALBUMINURIA: A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL by Greeviroj, P., Puapatanakul, P., Phannajit, J., Takkavatakarn, K., Kittanamongkolchai, W., Boonchaya-Anant, P., Katavetin, P., Praditpornsilpa, K., Susantitaphong, P.

Get full text

WCN23-0420 EPIDEMIOLOGY OF AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY DISEASE: A SINGLE-CENTER RETROSPECTIVE COHORT by TITICHOATRATTANA, S., Kulvichit, W., Mukdavannakorn, S., Boonvisut, N., Phannajit, J., Katavetin, P., Susanthitapong, P., Tungsanga, K., Tungsanga, S.

Get full text

Wrong primer for rat angiotensinogen mRNA by Katavetin, Pisut, Nangaku, Masaomi, Fujita, Toshiro

Get more information